NYSE: NVS
Novartis AG (NVS)
Novartis AG is a public company that reports to the U.S. Securities and Exchange Commission and trades on NYSE under the ticker NVS. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.
Key facts
- Ticker symbol
- NVS
- Exchange
- NYSE
- SEC CIK
- 1114448
- Official filings
- SEC EDGAR
Research NVS
- Profile — Business description, headquarters, subsidiaries and corporate identifiers.
- Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
- SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
- Stock Analysis — Price chart, returns, technical indicators and related companies.
- News — Latest headlines and press coverage.
- Material Contracts — Material agreements filed as exhibits to SEC reports.
- Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
- Peer Comparison — Side-by-side financial ratios against industry peers.
Frequently asked questions
What is Novartis AG's stock ticker?
Novartis AG trades under the ticker symbol NVS on NYSE. Its SEC Central Index Key (CIK) is 1114448.
Where can I read Novartis AG's SEC filings?
The NVS SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Novartis AG has filed, with AI analysis. The original documents are also on SEC EDGAR.
How can I analyze NVS's financial statements?
The NVS Financials page shows Novartis AG's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.
How does NVS compare with its peers and the market?
The NVS Peer Comparison page lines Novartis AG up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.
For information only — not investment advice.